TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
INDV

Indivior Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

36.40$ +0.4% vs. previous close Closing price · As of: Nov 2, 2026

Investor relations

Report Dates

Investor relations overview for Indivior Pharmaceuticals, Inc. (INDV): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 10/29/2026.

Next report 10/29/2026
Last report 08/03/2026
Earnings surprise by quarter (%)
Q4 23 · 53.6 % 23 Q1 24 · -11.9 % 24 Q2 24 · 10.0 % 24 Q3 24 · -90.3 % 24 Q4 24 · 22.7 % 24 Q1 25 · 78.3 % 25 Q2 25 · 104.0 % 25 Q3 25 · 75.6 % 25 Q4 25 · 26.2 % 25 Q1 26 · 45.5 % 26 Q2 26 · 18.6 % 26

EPS estimate beaten

Full history 18 of 33 quarters (55%)
Last 16 quarters 11 of 16 quarters (69%)

Earnings Call Transcripts

Search all transcripts →

  • 08/04/2026 Earnings Call Q2 2026 Open →
  • 04/30/2026 Earnings Call Q1 2026 Open →
  • 02/26/2026 Earnings Call Q4 2025 Open →
  • 10/30/2025 Earnings Call Q3 2025 Open →
  • 08/01/2025 Earnings Call Q2 2025 Open →
  • 04/24/2025 Earnings Call Q1 2025 Open →
  • 02/20/2025 Earnings Call Q4 2024 Open →
  • 10/24/2024 Earnings Call Q3 2024 Open →
  • 07/25/2024 Earnings Call Q2 2024 Open →
  • 04/25/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 11/03/2026 Supernus, Inc. (INDV): Other Events · sec.gov Open ↗
  • 11/02/2026 Indivior Pharmaceuticals, Inc. (INDV): Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Regulation FD Disclosure; Fin · sec.gov Open ↗
  • 10/29/2026 Indivior Pharmaceuticals, Inc. (INDV): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 10/15/2026 Indivior Pharmaceuticals, Inc. (INDV): Submission of Matters to a Vote of Security Holders · sec.gov Open ↗
  • 10/06/2026 Indivior Pharmaceuticals, Inc. (INDV): Other Events · sec.gov Open ↗
  • 09/17/2026 Indivior Pharmaceuticals, Inc. (INDV): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 09/15/2026 Indivior Pharmaceuticals, Inc. (INDV): Termination of a Material Definitive Agreement; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/03/2026 Indivior Pharmaceuticals, Inc. (INDV): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/03/2026 Indivior Pharmaceuticals, Inc. (INDV): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/03/2026 Indivior Pharmaceuticals, Inc. (INDV): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?